Control of entry changes warning
The Government's proposed changes to the control of entry regulations might reduce rather than increase competition and choice for patients, according to the United Co-operative Group.
Steve Coleman, retail pharmacy operations manager, told The Journal that
although the company welcomes the Government’s intention to simplify
the applications and appeals process, it has a number of concerns. “It
is unclear how existing contractors will be given the opportunity to
demonstrate their commitment and capability to meet local needs,” he
said. “If the test were robust there would be no reason to introduce
any form of exemption. The proposals demonstrate no patient need for
these ‘special cases’ and they will adversely impact patient
choice because no assessment on the existing pharmaceutical services
is undertaken.”
Mr Coleman also pointed out the exemptions might create unnecessary complexity
and increase the risk of legal action to resolve disputes. “Exemptions
could also increase the number of contractors that cannot be supported
by the existing number of pharmacists or government finances,” he
added. This would lead to closures and no overall improvement for patients. |
